Topics

Kaleido Biosciences Company Profile

04:00 EST 24th January 2020 | BioPortfolio

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome's natural roles in promoting health.


News Articles [620 Associated News Articles listed on BioPortfolio]

Kaleido Exec Brumm Is Stepping Down to Become CEO of Another Biotech

Joshua Brumm, chief operating and chief financial officer of Kaleido Biosciences (NASDAQ: KLDO) since last year, will step down on Oct. 11. Lexington, MA-based Kaleido said that Brumm is leaving to be...

Dyne Appoints Brumm President & CEO, Subramanian Shifts to CSO

Joshua Brumm has been appointed president and CEO of Dyne Therapeutics. Romesh Subramanian, Dyne’s founder and former CEO, has shifted to a new role as chief scientific officer. Brumm will join Walt...

Kaleido Collaborates with Janssen on Metabolic Therapies

Kaleido announced a research collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson on metabolic therapies. The post Kaleido Collaborates with Janssen on Metabolic Therapies...

Kaleido joins forces with Janssen on microbiome metabolic therapies

Janssen and Kaleido have agreed to explore the potential of microbiome metabolic therapies to prevent onset of childhood allergy and other atopic, immune and metabolic conditions

Management tracks: Epizyme, Disarm, Kaleido, Selecta and more

Inflection, AUM Biosciences partner to develop cancer treatments

Inflection Biosciences, an Irish drug developer, has signed an international deal with AUM Biosciences of Singapore for the d -More- 

AUM Biosciences to develop Inflection’s cancer therapy

Biotechnology firm AUM Biosciences has entered a global licence agreement for Inflection Biosciences’ series of PIM/PI3K/mTOR inhibitor molecules. Under the...Read More... The post AUM Biosciences t...

Curriculum Reforms in Uganda Integrate Modern Biosciences

Years of relentless efforts led by Uganda Biosciences Information Center (UBIC) to integrate modern biosciences into Uganda's middle/secondary schools' curriculum were finally rewarded. Uganda's Minis...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]

natelleONE

Isoproterenol hydrochloride [amneal biosciences llc]

Isoproterenol Hydrochloride Injection, USP Rx only Sterile Injection

Spherusol [nielsen biosciences, inc.]

These highlights do not include all the information needed to use Spherusol safely and effectively. See full prescribing information for Spherusol . Coccidioides immitis Spherule-Derived Skin Test Ant...

Natelle one [azur pharma, inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [52 Associated PubMed Articles listed on BioPortfolio]

Heineken, Tsuchiya and Aris on the Mathematical Status of the Pseudo-steady State Hypothesis: a Classic from Volume 1 of Mathematical Biosciences.

Volume 1, Issue 1 of Mathematical Biosciences was the venue for a now-classic paper on the application of singular perturbation theory in enzyme kinetics, "On the mathematical status of the pseudo-ste...

A genomic extension to the sequence of HLA-A*02:13, identified using Third-Generation Sequencing.

Pacific Biosciences' SMRT sequencing method was used to extend the sequence of HLA-A*02:13. This article is protected by copyright. All rights reserved.

How the diversity of the faces arises.

The evolution of the face is crucial for each species to adapt to different diets, environments, and in some species, to promote social interaction. The diversity in the shapes of the face results fro...

Regulation of IGF-1 by IGFBP3 and IGFBP5 during odontoblast differentiation in mice.

Although intracellular signaling pathways of insulin-like growth factor 1 (IGF-1) related to the proliferation of dental pulp cells have been investigated, the switching mechanism from cell proliferat...

Degradation of extracellular matrices propagates calcification during development and healing in bones and teeth.

Bone, dentin, and enamel are tissues formed through calcification, a process involving deposition of calcium phosphate minerals on extracellular organic matrices. Calcification, the underlying mechani...

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer

The drug for this submission is Hope Biosciences' allogeneic, first blood relative, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSCs) for the treatment of a single patien...

Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Parkinson's Disease

The drug for this submission is Hope Biosciences' autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC's) for the treatment of a single patient with Parkinson's Di...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Companies [408 Associated Companies listed on BioPortfolio]

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The ...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

More Information about "Kaleido Biosciences" on BioPortfolio

We have published hundreds of Kaleido Biosciences news stories on BioPortfolio along with dozens of Kaleido Biosciences Clinical Trials and PubMed Articles about Kaleido Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kaleido Biosciences Companies in our database. You can also find out about relevant Kaleido Biosciences Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record